Celastrus paniculatus oil ameliorates synaptic plasticity in a rat model of attention deficit hyperactivity disorder
- 1 January 2021
- journal article
- research article
- Published by Medknow in Asian Pacific Journal of Tropical Biomedicine
- Vol. 11 (3), 105-114
- https://doi.org/10.4103/2221-1691.306690
Abstract
Objective: To explore the effect and mechanism of action of Celastrus paniculatus oil on the treatment of perinatal rats with attention deficit hyperactivity disorder. Methods: In the perinatal stage, the rats were either isolated or administered with lead acetate to establish an animal model of attention deficit hyperactivity disorder. Atomoxetine served as the reference standard. Animals’ behaviours were assessed through Y-maze, novel object preference, fear conditioning and resident-intruder aggression tests. Oxidative stress parameters, bioamine concentration (dopamine, noradrenaline and 5-hydroxytryptamine), nerve growth factor, interleukin-6, nuclear factor-κB, and tumour necrosis factor (TNF)-α were estimated. Synaptophysin immunohistochemical assay was performed. Results: Celastrus paniculatus oil significantly improved behavioural parameters in Y maze, novel object preference, discrimination index, fear conditioning and resident intruder aggressive tests. The treatment groups showed a decrease in malondialdehyde level. Changes in the levels of dopamine, noradrenaline, and serotonin were restored by Celastrus paniculatus oil. Celastrus paniculatus oil increased nerve growth factor and decreased interleukin-6, nuclear factor-κB, and TNF-α. Synaptophysin immunoreactivity was also improved by Celastrus paniculatus oil with alleviated reactive gliosis, degeneration, and vascular proliferation. Conclusions: This research shows the therapeutic potential of Celastrus paniculatus oil for the treatment of attention deficit hyperactivity disorder.Keywords
This publication has 24 references indexed in Scilit:
- Antiulcerogenic activity of Scutia buxifolia on gastric ulcers induced by ethanol in ratsActa Pharmaceutica Sinica. B, 2014
- Serum nerve growth factor (NGF) levels in children with attention deficit/hyperactivity disorder (ADHD)Neuroscience Letters, 2014
- Trends in the Parent-Report of Health Care Provider-Diagnosed and Medicated Attention-Deficit/Hyperactivity Disorder: United States, 2003–2011Journal of the American Academy of Child & Adolescent Psychiatry, 2013
- Social isolation induces deficit of latent learning performance in mice: a putative animal model of attention deficit/hyperactivity disorderBehavioural Brain Research, 2013
- The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity DisorderBiological Psychiatry, 2011
- BEHAVIOURAL AND EMOTIONAL PROBLEMS IN SCHOOL GOING ADOLESCENTSAustralasian Medical Journal, 2011
- Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism - effects of medicationBehavioral and Brain Functions, 2010
- Dopamine–serotonin interactions in attention-deficit hyperactivity disorder (ADHD)Published by Elsevier BV ,2008
- Evaluation of anxiolytic potential of Celastrus oil in rat models of behaviourFitoterapia, 2007
- CatalasePublished by Elsevier BV ,1965